Hematology, Transfusion and Cell Therapy (Oct 2020)
A novel microrna signature with clinical significance in multiple myeloma
- A. Papanota,
- P. Artemaki,
- P. Karousi,
- C. Liacos,
- M. Gavriatopoulou,
- E. Kastritis,
- C. Kontos,
- M. Dimopoulos,
- A. Scorilas,
- E. Terpos
Affiliations
- A. Papanota
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece; Corresponding author.
- P. Artemaki
- Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Athens, Greece
- P. Karousi
- Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Athens, Greece
- C. Liacos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- M. Gavriatopoulou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- E. Kastritis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- C. Kontos
- Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Athens, Greece
- M. Dimopoulos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- A. Scorilas
- Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Athens, Greece
- E. Terpos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- Journal volume & issue
-
Vol. 42
pp. 23 – 24
